NuGEN Announces Co-Marketing Agreement with Qiagen
News May 04, 2006
The agreement will provide researchers with complete solutions for isolation, amplification, fragmentation and labeling of RNA for research purposes as well as for molecular diagnostics.
"We are always seeking new partners with complementary technologies who share our vision of providing our customers complete solutions for their RNA research, especially for small and complex samples," said Sue Pandey, vice president of commercial operations for NuGEN.
"This agreement represents a major step in our strategy of partnering with industry and technology leaders in life sciences."
"We believe Qiagen's recognized expertise and capabilities in preanalytical sample preparation and its reputation for highest quality and reliability will provide enormous value to our customers around the world who are using NuGEN's Ovation™ Systems for amplification."
Back in 2009, researchers identified a herd of Awassi sheep suffering from "day blindness". As that term implies, these sheep were blind during the day (in bright light) but could see at night, in low-light conditions. After identifying the genetic basis of this blindness, researchers have now successfully used gene therapy to restore their daytime vision.READ MORE